News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kapur Anil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 7,567 shares
@ $2.04, valued at
$15.4k
|
|
| 05/16/2023 |
4
| Kapur Anil (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.42, valued at
$26.3k
|
|
| 02/24/2023 |
4
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 625,000 options to buy
@ $2.83, valued at
$1.8M
|
|
| 01/03/2023 |
4
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 6,021 shares
@ $1.11, valued at
$6.7k
|
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 750,000 options to buy
@ $1.06, valued at
$795k
|
|
| 02/04/2021 |
4
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 300,000 options to buy
@ $2.055, valued at
$616.5k
|
|
| 12/04/2019 |
3
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 3 on GERON CORP |
| 12/04/2019 |
4
| Kapur Anil (EVP, Corp Strategy & CCO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 700,000 options to buy
@ $1.43, valued at
$1M
|
|
| 07/16/2019 |
4
| Kapur Anil (Chief Commercial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 02/08/2018 |
3
| Kapur Anil (Chief Commercial Officer) has filed a Form 3 on Actinium Pharmaceuticals, Inc. |
|
|